• Pantoprazole Sodium for Injection 40mg/10ml+10ml GMP Gastrointestinal Drug
  • Pantoprazole Sodium for Injection 40mg/10ml+10ml GMP Gastrointestinal Drug

Pantoprazole Sodium for Injection 40mg/10ml+10ml GMP Gastrointestinal Drug

Application: Internal Medicine
Usage Mode: Injection
Suitable for: Elderly, Children, Adult
State: Solid
Shape: Powder
Type: Organic Chemicals
Samples:
US$ 0/Piece 1 Piece(Min.Order)
| Request Sample
Customization:

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company

Basic Info.

Model NO.
AMC13030-03
Pharmaceutical Technology
Chemical Synthesis
OEM/ODM
Support
Transport Package
1′ S+1′ S/Box
Specification
40MG/10ML+10ML
Trademark
Shinepharm
Origin
China
HS Code
3004909099
Production Capacity
1000000 Boxes/Month

Product Description

Product Description

 

Pantoprazole Sodium for Injection 40mg/10ml+10ml GMP Gastrointestinal Drug

                
Indicatios:
Reflux oesophagitis.
Gastric and duodenal ulcer.
Zollinger-Ellison-Syndrome and other pathological hypersecretory conditions.
Dosage and administration:
Posology
Intravenous administration of Pantoprazole is recommended only if oral administration is not appropriate. Data are available on intravenous use for up to 7 days.
Recommended dose
The recommended intravenous dose is one vial of Pantoprazole (40 mg pantoprazole) per day.
Pantoprazole 40 mg powder for solution for injection is not recommended for use in patients below 18 years of age until further data become available.
A daily dose of 20 mg Pantoprazole should not be exceeded in patients with severe liver impairment.
Method of administration
This medicine should be administered by a healthcare professional and under appropriate medical supervision.
A ready-to-use solution is prepared in 10 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection. For instructions for preparation see section 6.6. The prepared solution may be administered directly or may be administered after mixing it with 100 ml sodium chloride 9 mg/ml (0.9 %) solution for injection or glucose 55 mg/ml (5 %) solution for injection.
After preparation the solution must be used within 6 hours.
The medicinal product should be administered intravenously over 2 - 15 minutes.

Contraindications:
Hypersensitivity to the active substance, substituted benzimidazoles, or to any of the excipients.
Drug interactions:
Effect of pantoprazole on the absorption of other medicinal products
Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may reduce the absorption of drugs with a gastric pH dependent bioavailability, e.g some azole antifungals as ketoconazole, itraconazole, posaconazole and other medicine as erlotinib.
HIV medications (atazanavir)
Coumarin anticoagulants (phenprocoumon or warfarin)
Methotrexate

Storage:
Keep the vial not reconstituted in the outer carton.
Do not store above 30 °C.

Store in the original package in order to protect from lightPantoprazole Sodium for Injection 40mg/10ml+10ml GMP Gastrointestinal Drug

 

 

 

Pantoprazole Sodium for Injection 40mg/10ml+10ml GMP Gastrointestinal Drug

 

 

 

 

 

 

Pantoprazole Sodium for Injection 40mg/10ml+10ml GMP Gastrointestinal Drug

 

 

 

 

 

 

 

Pantoprazole Sodium for Injection 40mg/10ml+10ml GMP Gastrointestinal Drug

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Management System Certification
ISO 9001, GMP, ISO 13485, FSC
Import & Export Mode
Have Own Export License